Since the dawn of 2025, the vibrant landscape of Hong Kong's new stock market has witnessed a sustained surge in activity. Emerging companies operating in cutting - edge fields like biotechnology, artificial intelligence, and intelligent driving have been fervently seeking to list on the Hong Kong Stock Exchange (HKEX). They are leveraging the avenues provided by Chapter 18A, Chapter 18C, and the De - SPAC mechanism within the Hong Kong stock listing rules.
Data released by the HKEX reveals that, as of the end of August, a total of 24 biotech firms have filed listing applications under Chapter 18A. Meanwhile, 12 specialized technology companies have also taken the plunge and submitted their listing applications via Chapter 18C.